// App-Quantinova.ai

: Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation

Researchers

Presenter

  • Joanne Kelly

Principal Investigators

  • Elizabeth Davies

  • Xan Xu

  • Jeffery Whitsett

  • Donna Davies

  • Hans Michael Haitchi

Medical Centers

  • Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton—Southampton, Southampton, United Kingdom

  • Division of Neonatology and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

  • Division of Neonatology, Perinatal and Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, Southampton, United Kingdom

  • NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, UK, Southampton, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Nucleoside diphosphate kinase A

  • Cluster of Differentiation 2AP

  • Granzyme B

  • NKp46

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved